Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
February 8, 2020
Personal and societal costs of multiple sclerosis in the UK: A population-based MS Registry study
Richard S Nicholas, Martin L Heaven, Rodden M Middleton, et al.
Plos One
|
November 2, 2016
Has Metal-On-Metal Resurfacing Been a Cost-Effective Intervention for Health Care Providers?-A Registry Based Study
Ruth Pulikottil-Jacob, Martin Connock, Ngianga-Bakwin Kandala, et al.
Orphanet Journal of Rare Diseases
|
April 17, 2020
Patient and caregiver perspectives on burden of disease manifestations in late-onset Tay-Sachs and Sandhoff diseases
Nicole Lyn, Ruth Pulikottil-Jacob, Camille Rochmann, et al.
Orphanet Journal of Rare Diseases
|
November 21, 2025
Burden of caregiving of individuals with GM1 and GM2 gangliosidoses in the United States: a qualitative study
Maria Belen Rodriguez, Ruth Pulikottil-Jacob, Karli Heuer, et al.
Advances in Therapy
|
May 27, 2024
Qualitative Study of the Patient Experience with Venglustat for Gaucher Disease Type 3 in a Phase 2 Open-Label, Multicenter, Multinational Study (LEAP)
Raphael Schiffmann, Eugen Mengel, Mary Wallace, et al.
Age and Ageing
|
February 10, 2017
The Community In-reach Rehabilitation and Care Transition (CIRACT) clinical and cost-effectiveness randomisation controlled trial in older people admitted to hospital as an acute medical emergency
Opinder Sahota, Ruth Pulikottil-Jacob, Fiona Marshall, et al.
Orphanet Journal of Rare Diseases
|
April 13, 2024
A retrospective study of morbidity and mortality of chronic acid sphingomyelinase deficiency in Germany
Eugen Mengel, Nicole Muschol, Natalie Weinhold, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
February 27, 2024
Assessment of health state utilities associated with adult and pediatric acid sphingomyelinase deficiency (ASMD)
Louis S Matza, Katie D Stewart, Marie Fournier, et al.
European Journal of Medical Genetics
|
June 9, 2024
Natural history of acid sphingomyelinase deficiency among European patients during childhood and adolescence: A retrospective observational study
Eugen Mengel, Maurizio Scarpa, Nathalie Guffon, et al.
Journal of Neuromuscular Diseases
|
May 21, 2025
Defining clinically meaningful thresholds for forced vital capacity in patients with neuromuscular disorders: Lessons learned from the COMET study in Pompe disease
Kenneth I Berger, Cristina Ivanescu, Jérôme Msihid, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
February 8, 2020
Personal and societal costs of multiple sclerosis in the UK: A population-based MS Registry study
Richard S Nicholas, Martin L Heaven, Rodden M Middleton, et al.
Plos One
|
November 2, 2016
Has Metal-On-Metal Resurfacing Been a Cost-Effective Intervention for Health Care Providers?-A Registry Based Study
Ruth Pulikottil-Jacob, Martin Connock, Ngianga-Bakwin Kandala, et al.
Orphanet Journal of Rare Diseases
|
April 17, 2020
Patient and caregiver perspectives on burden of disease manifestations in late-onset Tay-Sachs and Sandhoff diseases
Nicole Lyn, Ruth Pulikottil-Jacob, Camille Rochmann, et al.
Orphanet Journal of Rare Diseases
|
November 21, 2025
Burden of caregiving of individuals with GM1 and GM2 gangliosidoses in the United States: a qualitative study
Maria Belen Rodriguez, Ruth Pulikottil-Jacob, Karli Heuer, et al.
Advances in Therapy
|
May 27, 2024
Qualitative Study of the Patient Experience with Venglustat for Gaucher Disease Type 3 in a Phase 2 Open-Label, Multicenter, Multinational Study (LEAP)
Raphael Schiffmann, Eugen Mengel, Mary Wallace, et al.
Age and Ageing
|
February 10, 2017
The Community In-reach Rehabilitation and Care Transition (CIRACT) clinical and cost-effectiveness randomisation controlled trial in older people admitted to hospital as an acute medical emergency
Opinder Sahota, Ruth Pulikottil-Jacob, Fiona Marshall, et al.
Orphanet Journal of Rare Diseases
|
April 13, 2024
A retrospective study of morbidity and mortality of chronic acid sphingomyelinase deficiency in Germany
Eugen Mengel, Nicole Muschol, Natalie Weinhold, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
February 27, 2024
Assessment of health state utilities associated with adult and pediatric acid sphingomyelinase deficiency (ASMD)
Louis S Matza, Katie D Stewart, Marie Fournier, et al.
European Journal of Medical Genetics
|
June 9, 2024
Natural history of acid sphingomyelinase deficiency among European patients during childhood and adolescence: A retrospective observational study
Eugen Mengel, Maurizio Scarpa, Nathalie Guffon, et al.
Journal of Neuromuscular Diseases
|
May 21, 2025
Defining clinically meaningful thresholds for forced vital capacity in patients with neuromuscular disorders: Lessons learned from the COMET study in Pompe disease
Kenneth I Berger, Cristina Ivanescu, Jérôme Msihid, et al.
Page
of 4